The decrease in blood flow disrupts CV pruning. by Lin Wen (557398)

Mannan treatment induces a decreased phagocytic ability of B10.A and A/J macrophages. by Claudia Feriotti (286149)

Sulforaphane decreases IL-6, TNF-α, IL-17, and total IgG levels. by Su-Jin Moon (424173)

(R+S) and (R)-albuterol decrease NF-κB activity by Marcela A Ferrada (41716)

“…<p><b>Copyright information:</b></p><p>Taken from "(R)-albuterol decreases immune responses: role of activated T cells"</p><p>Respiratory Research 2008;9(1):3-3.…”

NFκB inhibition results in decreased IFNγ and IL-6 release. by Raquel M. Raices (370891)

TLR1/6 polymorphisms are associated with decreased lipopeptide-induced IL-6 and IL-10 production in PBMCs. by April Kaur Randhawa (125094)

Imatinib decreases phosphorylation of PDGF-r and c-Abl. by Ludovic Belle (293091)

Imatinib decreases <i>in vivo</i> proliferation of T-cells. by Ludovic Belle (293091)

Tan IIA decreased LPS-induced NF-κB activity in HSC-T6 cells. by Ya-Wei Liu (606320)

MR blockade by anti-MR antibodies decreases the phagocytic and fungicidal abilities and NO production of A/J and B10.A macrophages. by Claudia Feriotti (286149)

Decrease in circulating iNKT cell activation during regadenoson (RA) infusion into patients with COVID-19. by Joseph Rabin (7399436)

Subjects:

Everolimus decreased EC inflammation via lowered IL-1β and IL-6 expression in ECs. by Zsolt Fejes (844136)

Decrease of IL-6 and increase of IL-10 secretion in HESN derived-neutrophils after TLR4 stimulation. by Juan C. Hernandez (704571)

The mRNA expression of selected genes in cartilage cells after siRNA treatment were significantly decreased. by Fei Ye (339913)

Decreasing oxygen saturation with corresponding levels of NLR and D-dimer for understanding the interplay of inflammation. by Narendran Gopalan (110148)

IL-1Ra expressed by MSCs decreased Th17 differentiation. by Kijun Lee (4888660)

Decreasing ShcA expression enhances TGF-β-induced Smad signaling. by Baby Periyanayaki Muthusamy (838234)

“…(D, E) Decreasing ShcA expression, upon transfection of ShcA siRNA (siShc-a for NMuMG cells, siShc-c for HaCaT cells) but not control siRNA, enhances Smad3-mediated transcription, quantified by luciferase expression from a 4xSBE-luciferase reporter, in NMuMG (D) and HaCaT (E) cells, in the absence of or in response to 0.8 ng/ml TGF-β, or treated with SB431542, for 6 h. …”

A decrease in CD44+ cells in response to hypoxia. by Daniel V. Brown (3797809)

The G215S mutation decreases packaging of N and growth in primary differentiated human bronchial cells. by Hannah C. Kubinski (21213168)

Delphinidin alters VEGF-A splicing to increase VEGF-A₁₆₅b and decrease total VEGF-A expression. by Megan Stevens (3964886)

“…<p><b>A)</b> Treatment of podocytes with delphinidin chloride (10 μg/ml) under normal glucose (NG; 5 mM glucose + 25 mM mannitol) and high glucose (HG; 30 mM glucose, 1 ng/ml TNFα, 1 ng/ml IL-6, and 100 nM insulin) for 48 hrs increased the protein expression of VEGF-A₁₆₅b relative to total VEGF-A₁₆₅ (quantified in <b>B</b>; *p<0.05 vs NG, †p<0.05 vs HG; n = 3 biological repeats; One-way ANOVA with Bonferroni post-hoc test for comparison between pairs; <b>A</b>—the same blot was first probed with VEGF-A₁₆₅b before stripping and reprobing with panVEGF-A). …”